Here are six articles published by Becker's Hospital Review this week, highlighting a nationwide recall of an Abbott heart pump controller, a massive shortage of sodium bicarbonate solution in hospitals and more.
1. Abbott recalls heart pump controller following 26 patient deaths
Abbott Laboratories recalled nearly 29,000 controllers used with an implanted blood pump after more than two dozen heart patients died trying to replace the controller outside of a hospital setting.
2. Baking soda shortage forces hospitals to postpone surgeries, treatments
Hospitals nationwide are delaying major operations and chemotherapy due to a major shortage of a simple, yet crucial drug — sodium bicarbonate solution.
3. What Trump's budget proposal means for FDA funding
President Donald Trump's proposed 2018 federal budget would cut spending by $4.3 trillion over 10 years.
4. NY Medicaid program to inspect drugmakers who don't share discounts
New York state in April enacted new laws to address high drug costs as part of the state's budget.
5. Why FDA's newest approval paves the way for precision medicine
The Food and Drug Administration approved a new use for Merck's best-selling cancer drug, Keytruda, based on a patient's individual genetic makeup, rather than the physical location of the tumor.
6. Patient diagnosed with rare brain infection linked to Roche's new MS drug
A German patient was diagnosed with a potentially life-threatening brain infection after switching from Biogen's multiple sclerosis drug Tysabri to Roche's new Ocrevus MS treatment.
More articles on supply chain:
Biogen offshoot to acquire rare disease biotech for $400M: 4 things to know
Why FDA's newest approval paves the way for precision medicine
Supply chain tip of the day: How pharmacy can drive revenue for a health system post-merger